How can I tell if my night blindness is due to this genetic condition rather than a nutritional deficiency?

key difference is that night blindness from vitamin A deficiency often improves with supplementation and may be accompanied by other symptoms like dry eyes or night vision loss in both eyes. In contrast, autosomal dominant congenital stationary night blindness presents from birth or early childhood, remains stable over time, and is not responsive to vitamin A. A comprehensive eye exam and genetic testing can confirm the diagnosis.

What practical steps can I take to improve safety when driving or walking at night?

Use well‑lit pathways, avoid glare from streetlights, wear sunglasses that reduce glare during the day, and consider using a flashlight or headlamp with a warm‑white light. Some patients benefit from using a night‑vision aid or a smartphone app that enhances low‑light visibility. Always allow extra time for transitions between light and dark environments.

Does this condition worsen over time, and how often should I have eye exams?

The retinal changes are stationary, meaning they do not progress. However, regular eye exams every 1–2 years are recommended to monitor for unrelated eye issues such as cataracts or glaucoma, and to reassess visual function.

Are there any experimental treatments or clinical trials available for this retinal disorder?

Research is ongoing into gene therapy targeting the RHO, GNAT1, or PDE6B genes. Some early‑phase trials are recruiting participants, but these are limited to specific mutations and geographic regions. Patients interested in trials should consult a retinal specialist or research institution for eligibility and enrollment details.

Autosomal dominant congenital stationary night blindness

Autosomal dominant congenital stationary night blindness is a rare retinal disorder that causes lifelong difficulty seeing in low‑light conditions while daytime vision remains normal.

Overview

Autosomal dominant congenital stationary night blindness is a disorder of the retina, which is the specialized tissue at the back of that detects light and color. People with this condition typically have difficulty seeing and distinguishing objects in low light (night blindness). For example, they are not able to identify road signs at night and some people cannot see stars in the night sky. Affected individuals have normal daytime vision and typically do not have other vision problems related to this disorder.

The night blindness associated with this condition is congenital, which means it is present from birth. This vision impairment tends to remain stable (stationary); it does not worsen over time.

Frequency

Autosomal dominant congenital stationary night blindness is likely a rare disease; however, its prevalence is unknown.

Causes & Risk Factors

Mutations in the RHO, GNAT1, or PDE6B gene cause autosomal dominant congenital stationary night blindness. The proteins produced from these genes are necessary for normal vision, particularly in low‑light conditions. These proteins are found in specialized light receptor cells in the retina called rods. transmit visual signals from the eye to the brain when light is dim.

The RHO gene provides instructions for making a protein called rhodopsin, which is turned on (activated) by light entering the eye. Rhodopsin then attaches (binds) to and activates the protein produced from the GNAT1 gene, alpha (α)-transducin. The α‑transducin protein then triggers the activation of a protein called cGMP‑PDE, which is made up of multiple parts (subunits) including a subunit produced from the PDE6B gene. Activated cGMP‑PDE triggers a series of chemical reactions that create electrical signals. These signals are transmitted from rod cells to the brain, where they are interpreted as vision.

Mutations in the RHO, GNAT1, or PDE6B gene disrupt the normal signaling that occurs within rod cells. As a result, the rods cannot effectively transmit signals to the brain, leading to a lack of visual perception in low light.

Genes associated with Autosomal dominant congenital stationary night blindness

GNAT1
PDE6B
RHO

Inheritance

This condition is inherited in an autosomal dominant, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Other Names

AdCSNB
CSNBAD
Night blindness, congenital stationary, autosomal dominant

Additional Information & Resources

Genetic Testing Information

Genetic Testing Registry: Congenital stationary night blindness

Patient Support and Advocacy Resources

National Organization for Rare Disorders (NORD)

Catalog of Genes and Diseases from OMIM

NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3

Scientific Articles on PubMed

PubMed

References

Gal A, Orth U, Baehr W, Schwinger E, Rosenberg T. Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness. Nat Genet. 1994 May;7(1):64-8. doi: 10.1038/ng0594-64. Citation on PubMed
McAlear SD, Kraft TW, Gross AK. 1 rhodopsin mutations in congenital night blindness. Adv Exp Med Biol. 2010;664:263-72. doi: 10.1007/978-1-4419-1399-9_30. Citation on PubMed
Szabo V, Kreienkamp HJ, Rosenberg T, Gal A. p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Hum Mutat. 2007 Jul;28(7):741-2. doi: 10.1002/humu.9499. Citation on PubMed
Tsang SH, Woodruff ML, Jun L, Mahajan V, Yamashita CK, Pedersen R, Lin CS, Goff SP, Rosenberg T, Larsen M, Farber DB, Nusinowitz S. Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness. Hum Mutat. 2007 Mar;28(3):243-54. doi: 10.1002/humu.20425. Citation on PubMed or Free article on PubMed Central
Zeitz C, Gross AK, Leifert D, Kloeckener‑Gruissem B, McAlear SD, Lemke J, Neidhardt J, Berger W. Identification and functional characterization of a novel rhodopsin mutation associated with autosomal dominant CSNB. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4105-14. doi: 10.1167/iovs.08-1717. Epub 2008 May 16. Citation on PubMed

Medical Encyclopedia

Genetics
Vision - night blindness

Understanding Genetics

What is the prognosis of a genetic condition?
How can gene variants affect health and development?
What does it mean if a disorder seems to run in my family?
What are the different ways a genetic condition can be inherited?
How are genetic conditions treated or managed?